[3-[[3-(2-Amino-2-oxoethyl)-2-ethyl-1-(phenylmethyl)-1H-indol-5-yl]oxy]propyl]-phosphonicacid
中文名称 | [3-[[3-(2-Amino-2-oxoethyl)-2-ethyl-1-(phenylmethyl)-1H-indol-5-yl]oxy]propyl]-phosphonicacid |
---|---|
中文同义词 | 化合物 T22950 |
英文名称 | LY311727 |
英文同义词 | [3-[[3-(2-Amino-2-oxoethyl)-2-ethyl-1-(phenylmethyl)-1H-indol-5-yl]oxy]propyl]-phosphonicacid;LY 311727;Phosphonic acid, P-[3-[[3-(2-aMino-2-oxoethyl)-2-ethyl-1-(phenylMethyl)-1H-indol-5-yl]oxy]propyl]-;(3-{[3-(2-amino-2-oxoethyl)-1-benzyl-2-ethyl-1H-indol-5-yl]oxy}propyl)phosphonic acid;(3-{[3-(2-amino-2-oxoethyl)-1-benzyl-2-ethyl-1H-indol-5-yl]oxy}propyl)phosphonic acid (ApexBio);3-(1-Benzyl-2-ethyl-3-carboxamido-methyl-indol-5-yl)-oxy-propan-ephosphonic acid |
CAS号 | 164083-84-5 |
分子式 | C22H27N2O5P |
分子量 | 430.43 |
EINECS号 | |
相关类别 | |
Mol文件 | 164083-84-5.mol |
结构式 | ![]() |
[3-[[3-(2-Amino-2-oxoethyl)-2-ethyl-1-(phenylmethyl)-1H-indol-5-yl]oxy]propyl]-phosphonicacid 性质
沸点 | 758.2±70.0 °C(Predicted) |
---|---|
密度 | 1.32±0.1 g/cm3(Predicted) |
储存条件 | 2-8°C |
溶解度 | 在DMSO中的溶解度≥15mg/mL |
酸度系数(pKa) | 2.43±0.10(Predicted) |
形态 | 粉末 |
颜色 | 白色至棕褐色 |
[3-[[3-(2-Amino-2-oxoethyl)-2-ethyl-1-(phenylmethyl)-1H-indol-5-yl]oxy]propyl]-phosphonicacid 用途与合成方法
sPLA 2
LY-311727 (0.1-10 μM) suppresses the contractile responses induced by human non-pancreatic secretory phospholipase A
2
(hnps-PLA
2
), in a concentration related manner.
LY-311727 nearly abolishes the hnps-PLA
2
responses at 1μM, while it failed to suppress porcine pancreatic PLA
2
concentration response curves at the same concentration.
LY-311727 displays 1,500-fold selectivity when assayed against porcine pancreatic s-PLA
2
.
LY-311727 (3-30 mg/kg; i.v.) dramatically suppresses the circulating enzyme activity in mice with Mt-sPLA
2
transgenic the intravenous (i.v.) administration.
Animal Model: | C57BL/6J mice, metallothionein promoter-human secretory PLA 2 minigene (Mt-sPLA 2 ) transgenic mice model |
Dosage: | 3 mg/kg, 10 mg/kg, 30 mg/kg |
Administration: | Intravenous injection |
Result: | Significantly and dose dependently suppressed the PLA 2 activity in the serum. |
安全信息
WGK Germany | 3 |
---|
更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
---|---|---|---|---|---|
2024/04/30 | HY-107393 | [3-[[3-(2-Amino-2-oxoethyl)-2-ethyl-1-(phenylmethyl)-1H-indol-5-yl]oxy]propyl]-phosphonicacid LY-311727 | 164083-84-5 | 5mg | 2800元 |